The Globe and Mail7m
Stocks Rally on Dovish PCE Inflation Report
Eli Lilly (LLY) closed up +1.14% after its competitor Novo Nordisk A/S (NOVOB DC) announced disappointing results from its experimental weight loss drug, CagriSema, which prompted a plunge of -20% in ...
The Globe and Mail9m
Stocks Pare Losses on Dovish PCE Report, But Threats Remain from Triple-Witching and Government Shutdown
Eli Lilly (LLY) is up more than +4% after its competitor Novo Nordisk A/S (NOVOB DC) announced disappointing results from its experimental weight loss drug, CagriSema, which prompted a plunge of about ...